{"id":"https://openalex.org/W4310103252","doi":"https://doi.org/10.1182/blood-2022-163821","title":"Health-Related Quality of Life Reported Among Patients with Paroxysmal Nocturnal Hemoglobinuria: Impact of Treatment with Pegcetacoplan and C5-Inhibitors","display_name":"Health-Related Quality of Life Reported Among Patients with Paroxysmal Nocturnal Hemoglobinuria: Impact of Treatment with Pegcetacoplan and C5-Inhibitors","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310103252","doi":"https://doi.org/10.1182/blood-2022-163821"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-163821","doi":"https://doi.org/10.1182/blood-2022-163821","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-163821","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080314729","display_name":"Dharmik Desai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120540","display_name":"Apellis Pharmaceuticals (United States)","ror":"https://ror.org/0231n7e68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210120540"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dharmik Desai","raw_affiliation_strings":["1Apellis Pharmaceuticals, Inc., Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Apellis Pharmaceuticals, Inc., Waltham, MA","institution_ids":["https://openalex.org/I4210120540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077321428","display_name":"Nandini Hadker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nandini Hadker","raw_affiliation_strings":["2Trinity Life Sciences, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Trinity Life Sciences, Waltham, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Amanda Francis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda Francis","raw_affiliation_strings":["2Trinity Life Sciences, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Trinity Life Sciences, Waltham, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032496402","display_name":"Amanda Cassidy Torres","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda Cassidy Torres","raw_affiliation_strings":["2Trinity Life Sciences, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Trinity Life Sciences, Waltham, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Laura Hill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Hill","raw_affiliation_strings":["2Trinity Life Sciences, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Trinity Life Sciences, Waltham, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054112773","display_name":"Jed Perler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jed Perler","raw_affiliation_strings":["2Trinity Life Sciences, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Trinity Life Sciences, Waltham, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007747233","display_name":"David Dingli","orcid":"https://orcid.org/0000-0001-7477-3004","observed_orcids":["https://orcid.org/0000-0001-7477-3004"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Dingli","raw_affiliation_strings":["3Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.1915,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.4138724,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"11445","last_page":"11446"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paroxysmal-nocturnal-hemoglobinuria","display_name":"paroxysmal nocturnal hemoglobinuria","score":0.9990000128746033},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pegcetacoplan","display_name":"pegcetacoplan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/c5-inhibitor","display_name":"C5 inhibitor","score":0.9179999828338623},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.8479999899864197},{"id":"https://openalex.org/keywords/patient-experience","display_name":"patient experience","score":0.5879999995231628},{"id":"https://openalex.org/keywords/treatment-switching","display_name":"treatment switching","score":0.5299999713897705},{"id":"https://openalex.org/keywords/most-bothersome-symptom","display_name":"most bothersome symptom","score":0.6610000133514404},{"id":"https://openalex.org/keywords/physical-activity-limitation","display_name":"physical activity limitation","score":0.4650000035762787},{"id":"https://openalex.org/keywords/stress","display_name":"stress","score":0.6039999723434448},{"id":"https://openalex.org/keywords/hopelessness","display_name":"hopelessness","score":0.8149999976158142},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.5460000038146973},{"id":"https://openalex.org/keywords/eculizumab","display_name":"eculizumab","score":0.6430000066757202},{"id":"https://openalex.org/keywords/romiplostim","display_name":"romiplostim","score":0.8330000042915344},{"id":"https://openalex.org/keywords/veltuzumab","display_name":"veltuzumab","score":0.38100001215934753}],"concepts":[{"id":"https://openalex.org/C2777346216","wikidata":"https://www.wikidata.org/wiki/Q1479494","display_name":"Paroxysmal nocturnal hemoglobinuria","level":2,"score":0.8531042337417603},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8516212701797485},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.7298427820205688},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4438692629337311},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.40011537075042725},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3794684410095215},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35757631063461304},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-163821","doi":"https://doi.org/10.1182/blood-2022-163821","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-163821","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4296468447","https://openalex.org/W2565137736","https://openalex.org/W4389220311","https://openalex.org/W4283377453","https://openalex.org/W4310102718","https://openalex.org/W4413410689","https://openalex.org/W4388952302","https://openalex.org/W4412550429","https://openalex.org/W1812191526","https://openalex.org/W4206837787"],"abstract_inverted_index":{"Background":[0],"Paroxysmal":[1],"nocturnal":[2],"hemoglobinuria":[3],"(PNH)":[4],"is":[5,257,262,319,324,518],"a":[6,27,134,155,233,251,313,384,427,476],"rare,":[7],"acquired":[8],"hematologic":[9],"condition":[10],"associated":[11],"with":[12,86,103,113,133,146,242,244,287,487],"significant":[13],"morbidity,":[14],"mortality,":[15],"and":[16,32,43,104,122,151,184,188,224,260,272,322,343,407,452,499,526,535],"impact":[17,36,55,356,478],"on":[18,59,250,278,296,312,359,381,383,423,460,463,481],"health-related":[19],"quality":[20,235],"of":[21,30,37,46,56,64,110,169,236,248,347,357,396,450,479,502,515],"life":[22,237],"(HRQoL).":[23],"PNH":[24,87,147,358,480],"leads":[25],"to":[26,52,99,138,140,154,173,178,210,218,292,305,331,338,363,374,378,420,441,457,474,491,506,520,528,532],"wide":[28],"range":[29],"symptoms,":[31],"patients":[33,69,81,119,129,143,172,194,231,265,353,370,425,493],"feel":[34,175,475],"the":[35,54,62,71,89,165,176,192,198,282,355,513,516,522],"their":[38,47,180,205,216,227,269,293,482],"illness":[39],"across":[40,368,393,496],"physical,":[41,270,497],"emotional,":[42,271,498],"social":[44,273,408,500],"aspects":[45],"lives.":[48],"This":[49,75,388],"study":[50,77,472],"sought":[51],"document":[53],"different":[57],"treatments":[58],"helping":[60],"alleviate":[61],"burden":[63],"disease,":[65],"as":[66,148,164,204,212,289],"reported":[67,126,202,232,266,354,392,494],"by":[68],"in":[70,88,197,430,435,439,448,455,470,504,509],"real-world":[72,523],"setting.":[73],"Methods":[74],"mixed-methods":[76],"enrolled":[78],"consenting,":[79],"adult":[80],"(>":[82],"21":[83],"years":[84],"old)":[85],"US":[90],"for":[91,186],"telephone":[92],"depth":[93],"interviews.":[94],"Eligible":[95],"participants":[96],"were":[97,298],"required":[98],"be":[100],"currently":[101],"treated":[102,241],"have":[105],"at":[106],"least":[107],"3":[108],"months":[109],"treatment":[111,132,275,486,534],"experience":[112,294,525],"pegcetacoplan.":[114,141,364],"Results":[115,116],"from":[117],"15":[118],"(8":[120],"female":[121],"7":[123,261,323],"male)":[124],"are":[125],"here.":[127],"All":[128,352],"had":[130],"received":[131],"C5-inhibitor":[135],"(C5-i)":[136],"prior":[137],"switching":[139,362,490],"Interviewed":[142],"described":[144,163],"living":[145],"frustrating,":[149],"exhausting,":[150],"uncertain,":[152],"leading":[153],"significantly":[156],"impacted":[157],"overall":[158,238,345,510],"HRQoL.":[159,228],"Fatigue":[160],"was":[161,371,390],"frequently":[162,214],"most":[166,286],"prominent":[167],"symptom":[168],"PNH,":[170,211],"causing":[171],"consistently":[174],"need":[177],"save":[179],"energy":[181],"throughout":[182],"days":[183],"weeks":[185],"essential":[187],"basic":[189],"tasks.":[190],"Of":[191],"N=15":[193],"who":[195],"participated":[196],"study,":[199],"n=13":[200],"(87%)":[201],"fatigue":[203],"Most":[206,417],"Bothersome":[207],"Symptom":[208],"due":[209],"it":[213,290],"limits":[215],"ability":[217,302,304,440,456],"carry":[219,332,442],"out":[220,333,443],"normal":[221],"daily":[222,334,444],"activities":[223],"negatively":[225],"impacts":[226],"On":[229],"average,":[230,461],"moderate":[234],"while":[239,277,295,422,462,484],"being":[240],"C5-is,":[243,297,424],"an":[245,344,507],"average":[246],"score":[247],"4.4":[249,379],"7-point":[252,314,385],"Likert":[253,315,386],"scale,":[254,316],"where":[255,317],"1":[256,318],"\"very":[258],"poor\"":[259],"\"excellent.\"":[263],"Furthermore,":[264],"not":[267],"achieving":[268],"HRQoL":[274,360,413,483],"goals":[276],"C5-is.":[279,488],"In":[280],"particular,":[281],"metrics":[283],"that":[284],"resonated":[285],"patients,":[288],"relates":[291],"continued":[299,473],"reduced":[300],"physical":[301,397,431],"(i.e.,":[303,336],"exercise,":[306],"walk,":[307],"or":[308,340],"jog)":[309],"(5.8":[310],"mean":[311,366,380],"\"never":[320],"true\"":[321],"\"always":[325],"true\"),":[326],"increased":[327],"stress":[328],"(5.5),":[329],"inability":[330],"commitments":[335],"going":[337],"work":[339],"school)":[341],"(5.3),":[342],"feeling":[346],"hopelessness":[348],"(4.8)":[349],"(Figure":[350,415,465],"1).":[351,416,466],"after":[361],"The":[365],"improvement":[367,389,429,434,438,447,454,495],"these":[369],"27%":[372],"compared":[373,377,419],"C5-is":[375,382],"(5.6":[376],"scale).":[387],"also":[391,527],"overarching":[394],"categories":[395],"(51%":[398],"relative":[399,404,410],"improvement,":[400,405,411],"N=15),":[401,406],"emotional":[402],"(41%":[403],"(33%":[409],"N=15)":[412],"measures":[414,501],"notably,":[418],"ratings":[421],"experienced":[426],"58%":[428,433],"ability,":[432],"stress,":[436],"42%":[437],"commitments,":[445],"41%":[446],"feelings":[449],"hopelessness,":[451],"52%":[453],"function":[458],"sexually,":[459],"pegcetacoplan":[464],"Conclusions":[467],"Patients":[468],"interviewed":[469],"this":[471],"negative":[477],"receiving":[485],"After":[489],"pegcetacoplan,":[492],"HRQoL,":[503],"addition":[505],"increase":[508],"QoL.":[511],"Capturing":[512],"Voice":[514],"Patient":[517],"crucial":[519],"characterize":[521],"patient":[524],"optimize":[529],"clinical":[530],"approaches":[531],"disease":[533],"management.":[536],"Figure":[537],"1View":[538,541],"largeDownload":[539,542],"PPTFigure":[540],"PPT":[543],"Close":[544],"modal":[545]},"counts_by_year":[{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2022-11-30T00:00:00"}